Reverse argument by MSD Korea, “No way! Gardasil is much cost-effective”

Although same data was used to analyze cost effectiveness, a result was completely reversed.

On the 16^th, MSD Korea announced an analysis result of comparing cases of vaccinating Gardasil, a cervical cancer vaccine, based on the ICER(Incremental Cost Effectiveness Ratio) standard. The ICER of Gardasil was approximately KRW 13.7 million, analyzed to have higher cost effectiveness than Cervarix’...